Biomapas Logo
Contact us
a
cropped-favicon-biomapas.png
Contact us
a

Smooth Switch to the EAEU Marketing Authorization for Medicinal Products

Webinar: Smooth Switch to the EAEU Marketing Authorization for Medicinal Products

The webinar will highlight the practical tips and guide you through the crucial steps of marketing authorization upgrade to the Eurasian Economic Union (EAEU) one, ultimately leading you towards a successful submission strategy development.

As of now, all national medicinal product marketing authorizations are valid in EAEU until their expiry date. However, the mentioned marketing authorizations must be revalidated according to the EAEU regulations until December 31st, 2025.

You will learn:

What do you need to prepare and implement now to timely and successfully transition to the EAEU marketing authorization?

  1. What are the main points you need to consider when going into the upgrade procedure?
  2. What do you need to know about EAEU GMP certification?
  3. What are the readability user testing requirements?
  4. Timelines

Preparing for a marketing authorization upgrade?

Create a successful submission strategy development. Explore your options in an informal chat.

Let's Talk

Who Should Attend?

Professionals from the following fields:

  • Regulatory Managers
  • Regulatory Strategy Managers
  • RA Partnerships Operations Manager
  • QA Managers supporting RA
  • RA Healthcare Compliance Managers

Duration: 45 min.

Speaker: Regulatory Affairs Project Manager CIS, Nargiz Asgarova, who will share her expertise regarding drug registration in the Eurasian Economic Union.

Nargiz Asgarova

Nargiz Asgarova

Regulatory Affairs Project Manager CIS

Other content that might interest you:

Harmonizing Product Information Across Baltic Markets

Harmonizing Product Information Across Baltic Markets

Aug 8, 2025

Navigating multilingual product information across several markets can be complex – but it doesn’t have to be. In this case study, we share how one of our partner companies successfully harmonized their SmPC, PIL, and labelling across the Baltic region, working with...

read more
Dossier Transformation for Market Expansion

Dossier Transformation for Market Expansion

Aug 8, 2025

Struggling with outdated dossiers and complex regulatory requirements? We partnered with a large pharma company to transform a fragmented legacy submission into a fully CTD-compliant dossier for successful market expansion in Europe. In this case study, we break down...

read more
Whitepaper: Computerised System Validation & Pharmacovigilance

Whitepaper: Computerised System Validation & Pharmacovigilance

Gain insights into optimised CSV solutions, and their role in effective risk management. Key Highlights: In-depth CSV risk management strategies Ensuring data integrity and reliability in PV systems Case study on validating a cloud-based safety database At Biomapas,...

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.
Affiliate-Based Outsourcing
CSV For Pharmacovigilance Systems
Early Phase Oncology
Functional Service Provision
M&A Support

Clinical Research

Read more

Regulatory Affairs

Read more

Pharmacovigilance

Read more

Medical Information

Read more